We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+6.64%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$13.4B
AUM Growth
+$421M
(+3.2%)
Cap. Flow
-$231M
Cap. Flow
% of AUM
-1.73%
Top 10 Holdings %
Top 10 Hldgs %
18.95%
Holding
286
New
38
Increased
90
Reduced
103
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$95.8M |
| 2 |
Mettler-Toledo International
MTD
|
+$89.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$66.9M |
| 4 |
Carnival Corporation Ltd
CCL
|
+$64.4M |
| 5 |
Walt Disney
DIS
|
+$62.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steris
STE
|
+$102M |
| 2 |
Abbott
ABT
|
+$97.9M |
| 3 |
MGM Resorts International
MGM
|
+$97.5M |
| 4 |
Bank of America
BAC
|
+$90.9M |
| 5 |
Philip Morris
PM
|
+$88.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.01% |
| 2 | Healthcare | 16.54% |
| 3 | Industrials | 13.55% |
| 4 | Financials | 11.42% |
| 5 | Consumer Discretionary | 11.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.49T
| $374M | 2.79% |
4,401,700
-129,700
| -3% | -$10.3M |
|
2
Apple
AAPL
$4.89T
| $342M | 2.55% |
7,388,616
-256,872
| -3% | -$11.6M |
|
3
Meta Platforms (Facebook)
META
$1.51T
| $309M | 2.3% |
1,588,025
-50,780
| -3% | -$9.18M |
|
4
Visa
V
$676B
| $255M | 1.9% |
1,922,214
-81,287
| -4% | -$10.5M |
|
5
Microsoft
MSFT
$2.83T
| $250M | 1.86% |
2,532,793
-56,367
| -2% | -$5.46M |
|
6
Alphabet (Google) Class C
GOOG
$3.9T
| $232M | 1.73% |
4,164,100
+259,180
| +7% | +$14M |
|
7
Cooper Companies
COO
$13.7B
| $198M | 1.48% |
3,361,064
+517,312
| +18% | +$29.6M |
|
|
ANDV
8
DELISTED
Andeavor
ANDV
| $197M | 1.47% |
1,503,753
+355,570
| +31% | +$46.8M |
|
|
9
Mettler-Toledo International
MTD
$26.8B
| $195M | 1.46% |
337,748
+156,676
| +87% | +$89.4M |
|
|
10
Alphabet (Google) Class A
GOOGL
$3.9T
| $187M | 1.4% |
3,312,800
+42,100
| +1% | +$2.29M |
|
11
Home Depot
HD
$332B
| $183M | 1.36% |
937,188
+37,825
| +4% | +$7.07M |
|
12
Ametek
AME
$55.5B
| $176M | 1.31% |
2,437,522
-128,135
| -5% | -$9.49M |
|
13
UnitedHealth
UNH
$382B
| $173M | 1.29% |
706,845
-5,247
| -0.7% | -$1.26M |
|
14
Salesforce
CRM
$134B
| $171M | 1.28% |
1,252,984
-34,632
| -3% | -$4.42M |
|
15
Boeing
BA
$165B
| $171M | 1.27% |
508,268
+43,127
| +9% | +$14.8M |
|
16
Union Pacific
UNP
$183B
| $169M | 1.26% |
1,191,822
+104,691
| +10% | +$14.6M |
|
17
Jazz Pharmaceuticals
JAZZ
$15.9B
| $152M | 1.14% |
883,961
-319,444
| -27% | -$52.2M |
|
18
Vertex Pharmaceuticals
VRTX
$121B
| $148M | 1.11% |
871,856
+94,755
| +12% | +$14.7M |
|
19
ServiceNow
NOW
$102B
| $147M | 1.1% |
4,273,735
-266,265
| -6% | -$9.23M |
|
20
Constellation Brands
STZ
$22.2B
| $146M | 1.09% |
667,635
-61,215
| -8% | -$13.8M |
|
21
Adobe
ADBE
$89.5B
| $127M | 0.95% |
522,685
-118,279
| -18% | -$28M |
|
|
MDCO
22
DELISTED
Medicines Co
MDCO
| $120M | 0.9% |
3,281,183
+251,572
| +8% | +$8.17M |
|
23
DuPont de Nemours
DD
$18.6B
| $119M | 0.89% |
713,671
+2,777
| +0.4% | +$465K |
|
24
JB Hunt Transport Services
JBHT
$27.1B
| $119M | 0.89% |
976,462
+187,725
| +24% | +$23M |
|
25
Teledyne Technologies
TDY
$30.4B
| $119M | 0.88% |
595,388
+131,065
| +28% | +$25.9M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Westfield Capital Management held 286 positions worth $13.4B, up 3.2% from $13B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management's Q2 2018 filing shows 38 new, 90 increased, 103 reduced and 43 closed positions. Its largest new stake was Bristol-Myers Squibb: 1,238,227 shares worth $68.5M. The largest sale was Steris, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q2 2018 buy was Bristol-Myers Squibb: 1,238,227 shares worth $68.5M.
- Westfield Capital Management added most to Thermo Fisher Scientific in Q2 2018, an estimated $95.8M increase.
- Westfield Capital Management's biggest Q2 2018 reduction was Steris, cutting an estimated $102M.
- Westfield Capital Management fully exited MGM Resorts International in Q2 2018, selling an estimated $97.5M.
- Westfield Capital Management's ten largest holdings make up 19% of its $13.4B portfolio in Q2 2018.
- Westfield Capital Management opened 38 new positions and closed 43 in Q2 2018.
- Westfield Capital Management's portfolio value rose 3.2% quarter-over-quarter to $13.4B.
Based on Westfield Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.